Fig. 6

Luteolin enhanced antitumor efficacy of CDDP against xenograft model of ovarian cancer. Xenograft mice were treated with various doses of luteolin or cisplatin or in combination. a The tumor volume was measured three times a week. (n = 6). b Three weeks after treatment, the mice were sacrificed, and tumor weight were measured. (n = 6). *** P < 0.001, vs. control; ## P < 0.01, ### P < 0.001 vs. cisplatin. CDDP: cisplatin